Balse Elise, Boycott Hannah E
Unité de Recherche sur les Maladies Cardiovasculaires, le Métabolisme et la Nutrition, Faculté de Médecine Pitié-Salpêtrière, Sorbonne Universités, UPMC Univ. Paris VI, Inserm, UMRS 1166, Université Pierre et Marie Curie, Paris, France.
Department of Cardiovascular Medicine, John Radcliffe Hospital, University of Oxford, Oxford, United Kingdom.
Front Physiol. 2017 Oct 17;8:808. doi: 10.3389/fphys.2017.00808. eCollection 2017.
The shape of the cardiac action potential (AP) is determined by the contributions of numerous ion channels. Any dysfunction in the proper function or expression of these ion channels can result in a change in effective refractory period (ERP) and lead to arrhythmia. The processes underlying the correct targeting of ion channels to the plasma membrane are complex, and have not been fully characterized in cardiac myocytes. Emerging evidence highlights ion channel trafficking as a potential causative factor in certain acquired and inherited arrhythmias, and therapies which target trafficking as opposed to pore block are starting to receive attention. In this review we present the current evidence for the mechanisms which underlie precise control of cardiac ion channel trafficking and targeting.
心脏动作电位(AP)的形态由众多离子通道共同作用决定。这些离子通道的正常功能或表达出现任何功能障碍,都可能导致有效不应期(ERP)改变并引发心律失常。离子通道准确靶向质膜的潜在机制十分复杂,在心肌细胞中尚未得到充分阐明。新出现的证据表明,离子通道转运是某些获得性和遗传性心律失常的一个潜在致病因素,针对转运而非通道孔阻断的治疗方法开始受到关注。在本综述中,我们介绍了目前关于心脏离子通道转运和靶向精确控制机制的证据。